S100A9 as a Pharmacological Target Molecule in Inflammation and Cancer

E-ISSN： 2212-3873|15|2|97-104

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.15, Iss.2, 2015-06, pp. : 97-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dual Role of S100A8 and S100A9 in Inflammation-Associated Cancer

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 8, Iss. 4, 2009-12 ,pp. : 329-336

Bentham Science Publishers

Access to resources Recommend Favorite

ADAM9 as a Potential Target Molecule in Cancer

Current Pharmaceutical Design, Vol. 15, Iss. 20, 2009-07 ,pp. : 2282-2287

Bentham Science Publishers

Access to resources Recommend Favorite

The S100A8 and S100A9 Proteins are Attractive Targets to Modulate Inflammation

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 6, Iss. 3, 2007-08 ,pp. : 244-251

Bentham Science Publishers

Access to resources Recommend Favorite

ADAM10 as a Therapeutic Target for Cancer and Inflammation

Current Pharmaceutical Design, Vol. 15, Iss. 20, 2009-07 ,pp. : 2288-2299

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Intervention of Cyclooxygenase-2 and 5-Lipoxygenase Pathways. Impact on Inflammation and Cancer

Current Pharmaceutical Design, Vol. 11, Iss. 26, 2005-10 ,pp. : 3431-3447

Bentham Science Publishers

Access to resources Recommend Favorite